Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1Biocon
03 1Biocon Biologics
04 2Biosimilar Collaborations Ireland Limited
05 97Novo Nordisk
06 1ORIFARM GROUP AS
01 4CAT
02 1Flextouch Injectable Solution In Pre-Filled Pen
03 1INJ
04 10INJECTABLE;SUBCUTANEOUS
05 3INJECTION;SOLUTION
06 9Injectable Solution
07 1Injectable Solution In A Pre-Filled Pen
08 3Injectable Solution In Cartridge
09 1Injectable Solution In Pre-Filled Pen
10 2Injectable Solution In Vial
11 3Injection
12 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
13 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
14 3PED
15 2PFP
16 1Penfill Injectable Solution In Cartridge
17 1Pumpcart Injectable Solution In Cartridge
18 9SOLUTION
19 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
20 3SOLUTION;SUBCUTANEOUS
21 2SUSPENSION
22 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
23 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
24 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
25 35Solution For Injection
26 7Suspension For Injection
27 4Blank
01 11Allowed
02 22Approved
03 9Authorized
04 6Deregistered
05 11Marketed
06 10Originator
07 11Schedule D
08 32Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 13Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Penfill
07 1Fiasp Pumpcart
08 1Fiasp ultra-fast-acting
09 1Fiasp ultra-fast-acting FlexTouch
10 1Fiasp ultra-fast-acting Penfill
11 3Insulin Aspart Sanofi
12 1Insulin NovoNordisk NovoRapid
13 1Insulin NovoNordisk NovoRapid FlexPen
14 1Insulin NovoNordisk NovoRapid FlexTouch
15 1Insulin NovoNordisk NovoRapid Penfill
16 1Insulin NovoNordisk NovoRapid PumpCart Eml
17 2KIRSTY
18 2Kirsty
19 1MERILOG
20 1MERILOG SOLOSTAR
21 1NOVOLOG
22 1NOVOLOG FLEXPEN
23 1NOVOLOG FLEXTOUCH
24 1NOVOLOG INNOLET
25 1NOVOLOG MIX 50/50
26 1NOVOLOG MIX 70/30
27 1NOVOLOG MIX 70/30 FLEXPEN
28 2NOVOLOG MIX 70/30 PENFILL
29 1NOVOLOG PENFILL
30 2NOVOMIX 30
31 2NOVORAPID
32 2NovoMix 30
33 1NovoMix 30 FlexPen
34 1NovoMix 30 Penfill 3 mL
35 5NovoRapid
36 1NovoRapid FlexPen
37 2NovoRapid Flexpen
38 1NovoRapid Penfill
39 1NovoRapid Penfill 3 mL
40 1NovoRapid PumpCart
41 1NovoRapid® FlexPen®
42 1NovoRapid® Penfill®
43 3Novomix
44 1Novomix 30 Flexpen
45 1Novomix 30 Flexpen 100 U/ml
46 1Novomix 30 Novolet
47 1Novomix 30 Penfill
48 1Novomix 30 Penfill 100 U/ml
49 1Novomix 50 Flexpen
50 1Novomix 50 Penfill
51 1Novomix 70 Flexpen
52 1Novomix 70 Penfill
53 3Novorapid
54 3Novorapid Flexpen
55 1Novorapid Flextouch
56 1Novorapid Innolet
57 1Novorapid Novolet
58 2Novorapid Penfill
59 2Novorapid Pumpcart
60 1Novorapidfill
61 1RYZODEG 70/30
62 1Ryzodeg
63 1Ryzodeg FlexTouch
64 1Ryzodeg Flexpen
65 1Ryzodeg Flextouch
66 3Ryzodeg Penfill
67 3Ryzodeg®
68 3TRURAPI
69 2Truvelog Mix 30
01 7Australia
02 11Canada
03 6Italy
04 2Moldova
05 11Norway
06 10South Africa
07 9Spain
08 28Sweden
09 11Switzerland
10 17USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 10ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG SOLOSTAR
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 3ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 21/04/2021
Application Number : 20200727000046
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000057
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000064
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000121
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000114
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 50/50
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 50 UNITS/ML;50 UNITS/ML
Packaging :
Approval Date :
Application Number : 21810
Regulatory Info :
Registration Country : USA
